Financials
- Market Capitalization 69.88 M
- Employee 25
- Founded 2013
- CEO Ankit Mahadevia
- Website www.sperotherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00HXSJ1R2
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
15.79
売上高対価格比率
2.76
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 4109 | CRDF Cardiff Oncology, Inc. - Common Stock | 0.94 USD | -5.05% | +1.08% | +9.30% | -54.81% | 73.13 M USD | ||
| 4118 | MNOV MediciNova, Inc. - Common Stock | 1.44 USD | +1.41% | +3.60% | +6.67% | +10.77% | 70.88 M USD | ||
| 4127 | XBIT XBiotech Inc. - Common Stock | 2.27 USD | -1.30% | -0.44% | +0.89% | -27.94% | 69.21 M USD | ||
| 4133 | PLRX Pliant Therapeutics, Inc. - Common Stock | 1.11 USD | -3.48% | -2.63% | +4.72% | -31.06% | 68.73 M USD |